Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study [0.03%]
甲氨蝶呤单药治疗肺部结节病的疗效：一项单中心真实世界前瞻性研究
Anna Goljan-Geremek,Michał Bednarek,Monika Franczuk et al.
Anna Goljan-Geremek et al.
Introduction: The first-line therapy in chronic sarcoidosis, according to WASOG/ATS/ERS recommendations, is GCS. This therapy is associated with significant adverse effects and finally does not alter the natural history o...
Chronic obstructive pulmonary disease in Poland: distribution of patients according to the new GOLD 2011 classification. Cross-sectional survey [0.03%]
波兰慢性阻塞性肺病患者按全球防治倡议组织(GOLD)2011年新分类的分布状况：横断面调查
Stefan Wesołowski,Piotr W Boros,Tomasz Dębowski
Stefan Wesołowski
Introduction: In 2011 new classification for chronic obstructive pulmonary disease (COPD) was introduced, which are not based on the extent of airflow limitation alone, but also on symptoms and risk of exacerbation. The o...
The influence of sublingual immunotherapy on several parameters of immunological response in children suffering from atopic asthma and allergic rhinitis depending on asthma features [0.03%]
舌下免疫疗法对患有特应性哮喘和过敏性鼻炎的儿童若干免疫反应参数的影响取决于哮喘特征
Olga Ciepiela,Anna Zawadzka-Krajewska,Iwona Kotuła et al.
Olga Ciepiela et al.
Introduction: The clinical efficacy of sublingual immunotherapy (SLIT) has already been proven and is known to be high. Its influence on the immunological system of patients suffering from bronchial asthma was also examin...
Non-tuberculous mycobacterial lung disease (NT MLD ) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension [0.03%]
慢性血栓栓塞性肺动脉高压和特发性肺动脉高压患者的非结核分枝杆菌肺病(NTM-LD)
Ewelina Wilińska,Karina Oniszh,Ewa Augustynowicz-Kopeć et al.
Ewelina Wilińska et al.
Introduction: Non-tuberculous mycobacterial lung diseases (NTMLD) occur rarely and are diagnosed mainly in patients belonging to risk groups. Pulmonary hypertension (PH) has not been recognised as a risk factor for NTMLD ...
The utility of oesophageal pH monitoring in diagnosing gastroesophageal reflux disease-related chronic cough [0.03%]
食管pH监测在胃食管反流病相关慢性咳嗽诊断中的应用价值分析
Aleksandra Rybka,Kamila Malesa,Olga Radlińska et al.
Aleksandra Rybka et al.
Introduction: Chronic cough is a common medical complaint, which may deteriorate patients' quality of life and cause many complications. Gastroesophageal reflux disease (GERD) is one of the frequent reasons for chronic co...
[Non-tuberculous mycobacterial lung disease. Rare entity or emerging epidemiological problem?] [0.03%]
[非结核分枝杆菌肺病. 罕见疾病或日益突出的流行病学问题?]
Ewa Rowińska-Zakrzewska
Ewa Rowińska-Zakrzewska
[Microbiome of the lung] [0.03%]
[肺微生物组]
Dorota Górecka,Elżbieta Puścińska
Dorota Górecka
Piotr Bobik,Andrzej Siemiątkowski
Piotr Bobik
One of the fundamental elements of therapy in patients hospitalised in the Intensive Care Unit (ICU) is mechanical ventilation (MV). MV enables sufficient gas exchange in patients with severe respiratory insufficiency, thus preserving the p...
Iwona Stelmach,Anna Sztafińska,Joanna Lechańka et al.
Iwona Stelmach et al.
Urticaria is a heterogeneous group of disorders, with various clinical manifestations and intensity of symptoms. Urticaria can be induced with a wide variety of environmental stimuli, such as cold, pressure, vibration, sunlight, exercise, t...
[Pneumocystis pneumonia in HIV-infected patients with cytomegalovirus co-infection. Two case reports and a literature review] [0.03%]
人免疫缺陷病毒感染并发巨细胞病毒血症患者中肺炎孢子虫肺炎2例及文献回顾
Mateusz Marek Polaczek,Jacek Zych,Karina Oniszh et al.
Mateusz Marek Polaczek et al.
Pneumocystis pneumonia (PCP) is one of the infectious lung diseases diagnosed in HIV-infected patients. The pathogen responsible for the development of this opportunistic infection is an atypical fungus called Pneumocystis jiroveci. PCP rem...